Aarti Industries Limited will host its officials for investor interactions on September 22, 2026. The company confirmed the engagement as part of the Anand Rathi Annual Flagship Conference G-200 Summit 2026 in Mumbai.

The interactions will take place through a mix of one-on-one and group meetings. These sessions are subject to last-minute changes due to exigencies on the part of the investor or company.

Regulatory Disclosure

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Raj Kumar Sarraf, Company Secretary, signed the disclosure filed with both BSE and NSE.

Meeting Details

Aarti Industries commissioned Phase I of its Zone IV project at Jhagadia, Gujarat, on September 7, 2026. The facility brings Calcium Chloride, PEDA, and a part of the Multipurpose Plant on stream. This expansion strengthens the company’s downstream integration and flexible manufacturing capabilities.

The commissioning marks a milestone in Aarti Industries’ growth strategy. The new platform is designed to support the commercialisation of high-value and niche products. Several products planned from Zone IV are expected to be manufactured in India for the first time.

Facility Capabilities

Phase I integrates three key components to diversify end-use applications:

• PEDA (2-Phenyl Ethyl Diethyl Aniline): Extends the existing Ethylation platform downstream. It builds on established 2,6-Diethyl Aniline capabilities for value-added agrochemical applications.
• Calcium Chloride: Strengthens the Energy & Additives portfolio. Applications include oilfield and energy-related markets.
• Multipurpose Plant (MPP): Provides a flexible platform to scale pilot-validated processes into commercial production. This enables faster response to evolving customer requirements across multiple chemistries.

These facilities address applications spanning agrochemicals, pharmaceuticals, coatings, polymers, and energy & additives.

Strategic Outlook

Suyog Kotecha, Chief Executive Officer, stated that Zone IV was conceived as a flexible platform to deepen integration and add niche products. The company plans to progressively commercialise all manufacturing blocks within Zone IV during this fiscal year.

The broader Zone IV platform features multiple chemistry blocks designed for diverse chemistries. This strengthens the integrated R&D, scale-up, and manufacturing ecosystem. It forms a building block of the long-term speciality chemicals growth strategy.

What the Numbers Show

The source provides no financial figures, revenue data, or order values. Consequently, no analytical observation regarding financial performance or margins can be derived from this filing. The announcement focuses solely on operational capacity addition.